{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:03Z","timestamp":1791477903807,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development (CNPq)","doi-asserted-by":"publisher","award":["R37AG019391"],"award-info":[{"award-number":["R37AG019391"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development (CNPq)","doi-asserted-by":"publisher","award":["R01AG025442"],"award-info":[{"award-number":["R01AG025442"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development (CNPq)","doi-asserted-by":"publisher","award":["R01GM117518"],"award-info":[{"award-number":["R01GM117518"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbrc.2018.09.111","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T05:56:37Z","timestamp":1537595797000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified \u03b1-synuclein"],"prefix":"10.1016","volume":"505","author":[{"given":"Phelippe","family":"Carmo-Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Alex","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana R.","family":"Cortines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eliezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-0432","authenticated-orcid":false,"given":"Cristian","family":"Follmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.09.111_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.09.111_bib2","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2018.09.111_bib3","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In\u00a0vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2018.09.111_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(03)03354-7","article-title":"3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in\u00a0vivo: implications for Parkinson's disease pathogenesis","volume":"989","author":"Burke","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2018.09.111_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2010.03246.x","article-title":"Catechols in post-mortem brain of patients with Parkinson disease","volume":"18","author":"Goldstein","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-007-0303-9","article-title":"Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine","volume":"115","author":"Burke","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib7","doi-asserted-by":"crossref","first-page":"27660","DOI":"10.1074\/jbc.M115.686584","article-title":"Oligomerization and membrane-binding properties of covalent adducts formed by the interaction of \u03b1-synuclein with the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL)","volume":"290","author":"Follmer","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.09.111_bib8","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1002\/anie.201600277","article-title":"Toxic dopamine metabolite DOPAL forms an unexpected dicatechol pyrrole adduct with lysines of \u03b1-synuclein","volume":"20","author":"Werner-Allen","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbrc.2018.09.111_bib9","doi-asserted-by":"crossref","first-page":"40699","DOI":"10.1038\/srep40699","article-title":"DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function","volume":"7","author":"Plotegher","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.09.111_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbapap.2004.10.008","article-title":"Methionine oxidation, alpha-synuclein and Parkinson's disease","volume":"1703","author":"Glaser","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2018.09.111_bib11","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1111\/febs.12471","article-title":"\u03b1-Synuclein as an intrinsically disordered monomer \u2013 fact or artefact?","volume":"280","author":"Coelho-Cerqueira","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2018.09.111_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044913","article-title":"mMass as a Software Tool for the Annotation of Cyclic Peptide Tandem Mass Spectra","volume":"7","author":"Niedermeyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2018.09.111_bib13","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1021\/pr700859x","article-title":"Robust prediction of the MASCOT score for an improved quality assessment in mass spectrometric proteomics","volume":"7","author":"Koenig","year":"2008","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.bbrc.2018.09.111_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-61779-927-3_10","article-title":"Distance information for disordered proteins from NMR and ESR measurements using paramagnetic spin labels","volume":"895","author":"Eliezer","year":"2012","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jmb.2010.10.027","article-title":"The anti-Parkinsonian drug selegiline delays the nucleation phase of \u03b1-synuclein aggregation leading to the formation of nontoxic species","volume":"405","author":"Braga","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jmb.2007.07.008","article-title":"Residual structure, backbone dynamics, and interactions within the synuclein family","volume":"372","author":"Sung","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib17","first-page":"322","article-title":"Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening auto-inhibitory intra-molecular long-range interactions","volume":"1802","author":"Zhou","year":"2010","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2018.09.111_bib18","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2018.09.111_bib19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.biocel.2009.05.008","article-title":"Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells","volume":"41","author":"Parihar","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.09.111_bib20","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in\u00a0vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2018.09.111_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both a-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Nat. Acad. Sci. USA"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18320382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18320382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T04:02:51Z","timestamp":1543636971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18320382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0006291X18320382"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.111","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified \u03b1-synuclein","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}